News
BIXT
0.020
-6.51%
-0.001
Weekly Report: what happened at BIXT last week (0914-0918)?
Weekly Report · 8h ago
Weekly Report: what happened at BIXT last week (0907-0911)?
Weekly Report · 09/14 09:49
Weekly Report: what happened at BIXT last week (0831-0904)?
Weekly Report · 09/07 09:45
Weekly Report: what happened at BIXT last week (0824-0828)?
Weekly Report · 08/31 09:49
Weekly Report: what happened at BIXT last week (0817-0821)?
Weekly Report · 08/24 09:50
Weekly Report: what happened at BIXT last week (0810-0814)?
Weekly Report · 08/17 09:50
Based on the provided financial report articles, I generated the title for the article:
"Quarterly Financial Report for Q2 2026: [Company Name] Reports [Financial Results]"
Please note that the actual title may vary depending on the specific financial report and the company's reporting style.
Press release · 08/15 08:02
Bioxytran reports initial clinical observations from PLICID trial
TipRanks · 08/11 11:34
Weekly Report: what happened at BIXT last week (0803-0807)?
Weekly Report · 08/10 09:47
Weekly Report: what happened at BIXT last week (0727-0731)?
Weekly Report · 08/03 09:47
Weekly Report: what happened at BIXT last week (0720-0724)?
Weekly Report · 07/27 09:50
Weekly Report: what happened at BIXT last week (0713-0717)?
Weekly Report · 07/20 09:47
Weekly Report: what happened at BIXT last week (0706-0710)?
Weekly Report · 07/13 09:49
Weekly Report: what happened at BIXT last week (0629-0703)?
Weekly Report · 07/06 09:51
Weekly Report: what happened at BIXT last week (0622-0626)?
Weekly Report · 06/29 09:47
Weekly Report: what happened at BIXT last week (0615-0619)?
Weekly Report · 06/22 09:53
Weekly Report: what happened at BIXT last week (0608-0612)?
Weekly Report · 06/15 09:54
Weekly Report: what happened at BIXT last week (0601-0605)?
Weekly Report · 06/08 09:52
Weekly Report: what happened at BIXT last week (0525-0529)?
Weekly Report · 06/01 09:54
Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25
Barchart · 05/29 07:03
More
Webull provides a variety of real-time BIXT stock news. You can receive the latest news about Bioxytran Inc through multiple platforms. This information may help you make smarter investment decisions.
About BIXT
Bioxytran, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans. The Company's lead drug candidate, code named BXT-25, is an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer with intended applications, which includes the treatment of hypoxic conditions in the brain resulting from stroke. The Company, through its subsidiary, Pharmalectin Inc., is focused on the development, manufacturing, and commercialization of therapeutic drugs designed to address viral diseases in humans. Pharmalectin Inc. has developed a method designed to reduce the viral load and modulate the immune system using a galectin inhibitor. Its lead drug candidate, named ProLectin-Rx, is a complex polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin.